PCOS to PMOS: What the New Name Means

Yes. In 2026, an international consensus process selected polyendocrine metabolic ovarian syndrome (PMOS) as the new name for the condition long known as polycystic ovary syndrome (PCOS). The transition will take time, so you may see both names used together for years.

Most importantly, a new name does not erase your diagnosis or mean that your past care was wrong. It is intended to describe the condition more accurately and encourage broader, long-term care.

Why change the name PCOS?

“Polycystic ovary syndrome” has always caused confusion. The follicles sometimes seen on an ovary are not the same as typical ovarian cysts, and not everyone with the condition has polycystic ovarian morphology on a scan. At the same time, the condition can affect much more than the ovaries.

People may experience irregular ovulation or periods, higher androgen activity, acne, excess facial or body hair, fertility difficulties, insulin resistance and longer-term metabolic risks. The old name could make the condition sound like a cyst problem alone.

What does PMOS stand for?

Polyendocrine recognizes that several hormone systems can be involved. Metabolic highlights features such as insulin resistance and cardiometabolic risk. Ovarian keeps ovulation and reproductive health visible. Syndrome means a group of features that can appear in different combinations.

The name emerged from a multistep global consensus involving patients, clinicians, researchers and professional organizations across regions. The process prioritized scientific accuracy, clarity, cultural suitability and a transition that would not disrupt care.

Does the diagnosis change?

The name change does not automatically change who meets diagnostic criteria. Diagnosis still requires a careful history and assessment, with other causes excluded. The exact approach can differ for adults and adolescents, and no single symptom, blood test or ultrasound image should be interpreted alone.

If your records still say PCOS, you do not need to seek a repeat diagnosis simply because terminology is changing. Health records, coding systems, guidelines, insurance systems and patient materials may update at different speeds.

Does treatment change?

Not because of the name alone. Care should already be individualized around the features that matter to you, such as:

• menstrual regularity and protection of the uterine lining;
• acne or unwanted hair growth;
• fertility goals;
• sleep, mood and quality of life;
• blood pressure, glucose, cholesterol and other metabolic factors; and
• sustainable nutrition, activity and weight-neutral or weight-related goals agreed with you.

The new name may help clinicians and health systems remember that care should not stop at periods or fertility.

Will people still say PCOS?

Yes. During the transition, using “PMOS (formerly PCOS)” or “PCOS/PMOS” can help people find reliable information and connect old records with new terminology. Search engines, clinics and laboratories will not all change at once.

Be cautious with posts claiming that the rename proves one universal cause or one best diet, supplement or medicine. PMOS remains a varied condition, and treatment should match the individual.

What should you do now?

At your next routine appointment, ask how your clinic is recording the condition and whether your current plan covers both reproductive and metabolic health. Bring older results if you are seeing a new clinician. You do not need to change medication or repeat tests solely because the name changed.

The takeaway

PMOS is a more descriptive name for PCOS, not a brand-new disease. The goal is clearer understanding, less confusion about “cysts,” and more complete care across hormones, metabolism and ovarian function.

This article is general education and does not diagnose PMOS/PCOS or replace care from a qualified clinician.